Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial (Q46602972)
Jump to navigation
Jump to search
scientific article published on 10 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial |
scientific article published on 10 May 2008 |
Statements
1 reference
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial (English)
1 reference
Thalassemia Clinical Research Network
1 reference
Elliott Vichinsky
1 reference
Nancy Olivieri
1 reference
Janet L Kwiatkowski
1 reference
Patricia J Giardina
1 reference
Ellis J Neufeld
1 reference
Patrick B Walter
1 reference
Eric A Macklin
1 reference
John Porter
1 reference
Patricia Evans
1 reference
Thomas Coates
1 reference
Daniele Alberti
1 reference
Jaymes Holland
1 reference
Paul Harmatz
1 reference
10 May 2008
1 reference
1 reference
93
1 reference
6
1 reference
817-825
1 reference
Identifiers
1 reference
1 reference